4712 Stories, most recent news story added 1 hour 11 minutes ago
U.S. regulators are probing more cases of patients who were exposed to excess radiation from brain scans performed with equipment from General Electric and Toshiba, government officials said on Monday.
There is considerable confusion regarding how the North Dakota Department of Health's state laboratory is testing residents' specimens for the H1N1 virus this flu season.
FDA probing additional reports of excessive radiation from brain scans at California hospitals
At first glance, the Facebook fan page for Epilepsy Advocate is like many others, with regular updates, shared links and a small base of supporters. But the page, launched in October, is different from most in two crucial respects: it doesn't allow comments or even the ability to "like" an item.
Associated Press - December 7, 2009 4:44 PM ET WASHINGTON (AP) - Federal health regulators have identified 50 more patients exposed to dangerous radiation levels from brain scans at a hospital...
APCelgene Corp. in Summit in 2005SUMMIT -- Biotechnology company Celgene Corp. said today it will buy privately held Gloucester Pharmaceuticals Inc. for $640 million, getting access to key cancer drugs. The deal includes $340 million in cash upfront and $300...
Celgene Corp. (CELG) agreed to acquire privately-held drug maker Gloucester Pharmaceuticals Inc. for $340 million plus milestone payments of up to $300 million in a deal to bolster its position in blood cancer treatments.
Nutra Pharma has completed submission of the final Nyloxin OTC and Nyloxin Rx packaging and labeling to the Food and Drug Administration (FDA). This registration is considered the final step required by the FDA to begin selling Nyloxin OTC and Nyloxin Rx in the United States for the treatment of chronic pain. (PRWeb Dec 7, 2009) Read the full story at http://www.prweb.com/releases ...
NEW YORK - Celgene says it will buy privately held Gloucester Pharmaceuticals Inc. for $640 million, getting access to key cancer drugs. The deal includes $340 million...
Sees Expanding Opportunities in Using Stevia Sweetener in the Consumer Goods Industry
Friday P.M. Report A Sun Country bidder? And Cargill sued over E. coli, JetChoice sues Trooien, St. Jude device wins approval, and Delta traffic drops.
BD Diagnostics, a segment of BD , announced today it has received clearance from the U.S. Food and Drug Administration to utilize its BD ProbeTec Chlamydia trachomatis Qx and BD ProbeTec Neisseria gonorrhoeae Qx Amplified DNA Assays with samples collected during women's routine liquid-based Pap testing for cervical cancer screening.
TUCSON, Ariz.----RCT licensee Dyax Corp. has received approval from the U.S. Food and Drug Administration for KALBITOR® for the treatment of acute attacks of hereditary angioedema in patients 16 years of age and older.
Is one click enough? That is the crux of a debate between the Food and Drug Administration and the nation's biggest drug companies in a clash over applying rules written in an analog era to a digital world. The outcome will determine how prescription drugs are marketed to consumers.
Celgene Corporation (NASDAQ:CELG) and Gloucester Pharmaceuticals Inc., a privately held pharmaceutical company, announced a definitive merger agreement under which Celgene Corporation will acquire Gloucester Pharmaceuticals.
LOS ANGELES (AP) — A cold Pacific rainstorm is drenching California and dramatically dropping snow levels, bringing the usual spate of commuter calamities but so far sparing foothill burn areas of feared mud and debris flows.
